38
Participants
Start Date
August 20, 2015
Primary Completion Date
May 25, 2017
Study Completion Date
May 25, 2017
Subgam
Subgam-VF dose will be given as 1.37 of the established IGIV dose (expressed in mg/kg/week) for 26 weeks (26 infusions) beginning one week after the last IGIV infusion. Dose of Subgam-VF will then be adjusted based on the ratio of the Immunoglobulin G (IgG) average concentration achieved with Subgam-VF compared to IGIV.
O&O Alpan, LLC, Fairfax
Allergy Associate of the Palm Beaches, North Palm Beach
Optimed Research, Columbus
The Medical College of Wisconsin/Children's Hospital of Wisconsin, Milwaukee
Ann and Robert H Lurie Children's Hospital, Chicago
Cardinal Glennon Children's Medical Center, Minneapolis
Oklahoma Institute of Allergy & Asthma Clinical Research, LLC, Oklahoma City
Dallas Allergy Immunology, Dallas
AARA Research Center, Dallas
Immunoe International Research, Centennial
University of Utah, Salt Lake City
Arizona Allergy Associates, Chandler
University of California San Diego-- Rady's Children's Hospital, San Diego
University of California, Irvine, Irvine
Bellingham Asthma Allergy Clinic, Bellingham
Pennsylvania State University, Hershey
Lead Sponsor
Bio Products Laboratory
OTHER